{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T21:11:55Z","timestamp":1767906715343,"version":"3.49.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2001,2,1]],"date-time":"2001-02-01T00:00:00Z","timestamp":980985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2001,2,1]],"date-time":"2001-02-01T00:00:00Z","timestamp":980985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2001,2]]},"DOI":"10.1067\/mhj.2001.109952","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T00:18:43Z","timestamp":1027556323000},"page":"S15-S21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"S","title":["Pharmacologic management of atrial fibrillation: Current therapeutic strategies"],"prefix":"10.1067","volume":"141","author":[{"given":"Samuel","family":"L\u00e9vy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1067\/mhj.2001.109952_bib1","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJM198204293061703","article-title":"Epidemiologic features of chronic atrial fibrillation: the Framingham study","volume":"306","author":"Kannel","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2001.109952_bib2","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1001\/archinte.1987.00370090041008","article-title":"A major contributor to stroke in the elderly","volume":"147","author":"Wolf","year":"1987","journal-title":"Arch Int Med"},{"key":"10.1067\/mhj.2001.109952_bib3","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke;: The Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"key":"10.1067\/mhj.2001.109952_bib4","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1056\/NEJM199011293232201","article-title":"The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation","volume":"323","author":"BAATAF Investigators","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2001.109952_bib5","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1161\/01.CIR.84.2.527","article-title":"Stroke Prevention in Atrial Fibrillation Study: final results","volume":"84","author":"Stroke Prevention in Atrial Fibrillation Investigators (SPAF)","year":"1991","journal-title":"Circulation"},{"key":"10.1067\/mhj.2001.109952_bib6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM199507063330102","article-title":"Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia","volume":"333","author":"The European Atrial Fibrillation Trial Study Group","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2001.109952_bib7","first-page":"27","article-title":"The role of refractoriness, conduction velocity and wavelength in initiation of atrial fibrillation in normal dogs","author":"Allessie","year":"1989"},{"key":"10.1067\/mhj.2001.109952_bib8","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1161\/01.CIR.92.7.1954","article-title":"Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats","volume":"92","author":"Wijfells","year":"1995","journal-title":"Circulation"},{"key":"10.1067\/mhj.2001.109952_bib9","first-page":"583","article-title":"Nomenclature of atrial fibrillation or the Tower of Babel","volume":"9","author":"L\u00e9vy","year":"1998","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1067\/mhj.2001.109952_bib10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/j.1552-4604.1984.tb01822.x","article-title":"A classification of antiarrhythmic action reassessed after a decade of new drugs","volume":"24","author":"Vaughan-Williams","year":"1984","journal-title":"J Clin Pharmacol"},{"key":"10.1067\/mhj.2001.109952_bib11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0002-9149(92)91392-H","article-title":"Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension","volume":"70","author":"Capucci","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1067\/mhj.2001.109952_bib12","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/oxfordjournals.eurheartj.a062553","article-title":"Acute conversion of atrial fibrillation to sinus rhythm: clinical efficacy of flecainide acetate. Comparison of two regimens","volume":"9","author":"Crijns","year":"1988","journal-title":"Eur Heart J"},{"key":"10.1067\/mhj.2001.109952_bib13","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/0735-1097(90)90326-K","article-title":"The value of class 1C antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm","volume":"16","author":"Suttorp","year":"1990","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2001.109952_bib14","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0167-5273(94)90211-9","article-title":"A controlled study on oral propafenone versus digoxin plus quinidine in converting recent onset atrial fibrillation to sinus rhythm","volume":"43","author":"Capucci","year":"1994","journal-title":"Int J Cardiol"},{"key":"10.1067\/mhj.2001.109952_bib15","doi-asserted-by":"crossref","first-page":"621","DOI":"10.7326\/0003-4819-126-8-199704150-00006","article-title":"Oral propafenone to convert recent-onset atrial fibrillation in patients with and without underlying heart disease. A randomized controlled trial","volume":"126","author":"Boriani","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1067\/mhj.2001.109952_bib16","doi-asserted-by":"crossref","first-page":"503","DOI":"10.7326\/0003-4819-106-4-503","article-title":"Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. A randomized double-blinded trial","volume":"106","author":"Falk","year":"1987","journal-title":"Ann Inter Med"},{"key":"10.1067\/mhj.2001.109952_bib17","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/oxfordjournals.eurheartj.a015310","article-title":"Conversion of atrial fibrillation to sinus rhythm and rate control by digoxin in comparison to placebo","volume":"18","author":"Jordaens","year":"1997","journal-title":"Eur Heart J"},{"key":"10.1067\/mhj.2001.109952_bib18","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0002-9149(99)80655-9","article-title":"Flecainide versus amiodarone for recent onset atrial fibrillation","volume":"75","author":"Donovan","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1067\/mhj.2001.109952_bib19","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/0735-1097(95)00595-1","article-title":"Intravenous amiodarone in the treatment of recent-onset atrial fibrillation. Results of a randomized, controlled trial","volume":"27","author":"Galve","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2001.109952_bib20","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0735-1097(96)00121-0","article-title":"Conversion of atrial fibrillation and flutter by intravenous ibutilide: a multicenter dose response study","volume":"28","author":"Ellenbogen","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2001.109952_bib21","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0735-1097(96)00506-2","article-title":"Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter","volume":"29","author":"Falk","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2001.109952_bib22","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1540-8159.1983.tb05295.x","article-title":"Long-term prevention of vagal atrial arrhythmias by atrial pacing at 90\/minute: experience with 6 cases","volume":"6","author":"Coumel","year":"1983","journal-title":"PACE"},{"key":"10.1067\/mhj.2001.109952_bib23","first-page":"330","article-title":"Sympathetic nervous system and cardiac arrhythmias","author":"Schwartz","year":"1990"},{"key":"10.1067\/mhj.2001.109952_bib24","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/S0002-9149(97)00082-9","article-title":"Atrial fibrillation follow-up investigation of rhythm management: the AFFIRM study design","volume":"79","author":"The Planning and Steering Committees of the AFFIRM Study for the NHLBI AFFIRM Investigators","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1067\/mhj.2001.109952_bib25","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1161\/01.CIR.82.4.1106","article-title":"Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials","volume":"82","author":"Coplen","year":"1990","journal-title":"Circulation"},{"key":"10.1067\/mhj.2001.109952_bib26","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1161\/01.CIR.82.6.1932","article-title":"Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation","volume":"82","author":"Juul-Moller","year":"1990","journal-title":"Circulation"},{"key":"10.1067\/mhj.2001.109952_bib27","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0002-9149(91)90828-9","article-title":"Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter","volume":"68","author":"Crijns","year":"1991","journal-title":"Am J Cardiol"},{"key":"10.1067\/mhj.2001.109952_bib28","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/0002-9149(93)90511-A","article-title":"Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation","volume":"71","author":"Reimold","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1067\/mhj.2001.109952_bib29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1540-8167.1995.tb00758.x","article-title":"Paroxysmal atrial fibrillation: a need for a classification","volume":"6","author":"Levy","year":"1995","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1067\/mhj.2001.109952_bib30","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1161\/01.CIR.80.6.1557","article-title":"Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy","volume":"80","author":"Anderson","year":"1989","journal-title":"Circulation"},{"key":"10.1067\/mhj.2001.109952_bib31","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/0735-1097(88)90468-8","article-title":"Long term oral propafenone therapy for suppression of refractory symptomatic atrial fibrillation and atrial flutter","volume":"12","author":"Antman","year":"1988","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2001.109952_bib32","doi-asserted-by":"crossref","first-page":"539","DOI":"10.7326\/0003-4819-114-7-539","article-title":"Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias: a randomized, placebo-controlled, crossover trial in patients tolerating oral therapy","volume":"114","author":"Pritchett","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1067\/mhj.2001.109952_bib33","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0735-1097(92)90003-6","article-title":"Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation","volume":"20","author":"Flaker","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2001.109952_bib34","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1001\/jama.1992.03480240051033","article-title":"Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter","volume":"267","author":"Gosselink","year":"1992","journal-title":"JAMA"},{"key":"10.1067\/mhj.2001.109952_bib35","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJM200003303421302","article-title":"Amiodarone to prevent recurrences of atrial fibrillation","volume":"342","author":"Roy","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2001.109952_bib36","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1742-1241.1998.tb08896.x","article-title":"Amiodarone in atrial fibrillation","volume":"52","author":"Levy","year":"1998","journal-title":"Int J Clin Pract"},{"key":"10.1067\/mhj.2001.109952_bib37","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/0002-9149(90)90856-V","article-title":"Atrial proarrhthymic effects of class 1C antiarrhythmic drugs","volume":"66","author":"Feld","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1067\/mhj.2001.109952_bib38","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1161\/01.CIR.62.5.996","article-title":"Effects of intravenous and chronic oral verapamil","volume":"62","author":"Rikkenberger","year":"1980","journal-title":"Circulation"},{"key":"10.1067\/mhj.2001.109952_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005344-198901000-00002","article-title":"Effects of atenolol, verapamil, and xamoterol on heart rate and exercise tolerance in digitalized patients with chronic atrial fibrillation","volume":"13","author":"Lewis","year":"1989","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1067\/mhj.2001.109952_bib40","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1136\/hrt.63.4.225","article-title":"Time of occurrence, duration, and ventricular rate of paroxysmal atrial fibrillation: the effect of digoxin","volume":"63","author":"Rawles","year":"1990","journal-title":"Br Heart J"},{"key":"10.1067\/mhj.2001.109952_bib41","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1053\/euhj.1998.1050","article-title":"Atrial fibrillation: current knowledge and recommendations for management","volume":"19","author":"L\u00e9vy","year":"1998","journal-title":"Eur Heart J"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870301794082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870301794082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T04:49:15Z","timestamp":1757566155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870301794082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,2]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,2]]}},"alternative-id":["S0002870301794082"],"URL":"https:\/\/doi.org\/10.1067\/mhj.2001.109952","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2001,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacologic management of atrial fibrillation: Current therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1067\/mhj.2001.109952","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}